Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Depomed, Inc. (DEPO)

« Back to company index

DEPO Chatter Timeline

Stock Ticker for DEPO

Most Active Tweeters for DEPO

UserTweets
@happyycamperr 1
@confcalltran 1
@bbnsnews 1
@ExecPayOrg 1
@Allstocknews 1

Recent Tweets for DEPO

bbnsnews @bbnsnews
Head to Head Survey: Aduro BioTech $ADRO and Depomed $DEPO https://t.co/KYVIK0yoXy
April 17th 2019, 7:04am
happyycamperr @happyycamperr
@Ethyl_Eico similar to what $DEPO did with Glumetza for years
April 16th 2019, 1:04pm
WeekHerald @WeekHerald
Depomed $DEPO versus Aduro BioTech $ADRO Head to Head Survey https://t.co/leWN5mPQC4
April 15th 2019, 5:04am
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form DEF 14A (No. 0001047469-19-002034): https://t.co/nM4qQz9rNE
April 8th 2019, 6:04am
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form DEF 14A https://t.co/sjNGgRxYDI
April 8th 2019, 6:04am
Allstocknews @Allstocknews
$DEPO New Form DEF 14A for Assertio Therapeutics, Inc. From our Stock News Alerts App
April 8th 2019, 6:04am
ExecPayOrg @ExecPayOrg
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M https://t.co/eOoN8CmxQp $DEPO #execpay
April 8th 2019, 6:04am
confcalltran @confcalltran
Depomed releases salary data. CEO sees compensation rise 0%25 https://t.co/WVSm7YiONh $DEPO
April 8th 2019, 6:04am
confcalltran @confcalltran
Depomed director was just granted 37,475 restricted shares https://t.co/ihVbsXuiaT $DEPO
April 2nd 2019, 9:04am
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 3 https://t.co/aiDVJMqfeo
April 2nd 2019, 9:04am
confcalltran @confcalltran
Depomed director just declared 0 ownership of the company. https://t.co/sLd4wgPGEI $DEPO
April 2nd 2019, 9:04am
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form 8-K (No. 0001005201-19-000050): https://t.co/ut2hgVDHkB
April 1st 2019, 9:04am
confcalltran @confcalltran
Departure of Directors or Certain https://t.co/HWGHL8Qew9 $DEPO
April 1st 2019, 9:04am
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 8-K https://t.co/BXFHM2dsxS
April 1st 2019, 9:04am
Allstocknews @Allstocknews
$DEPO New Form 8-K for Assertio Therapeutics, Inc. From our Stock News Alerts App
April 1st 2019, 9:04am
Allstocknews @Allstocknews
$DEPO Assertio Therapeutics Announces Appointment of Jay Galeota to Board of Directors From our Stock News Alerts App
April 1st 2019, 9:04am
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form 8-K (No. 0001104659-19-018237): https://t.co/u4Qwx9YSFJ
March 28th 2019, 4:03pm
Allstocknews @Allstocknews
$DEPO Assertio Therapeutics Announces Favorable NUCYNTA® Patent Ruling From our Stock News Alerts App
March 28th 2019, 2:03pm
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 4 https://t.co/VaRc1GcPSK
March 18th 2019, 8:03am
Allstocknews @Allstocknews
$DEPO New Form 4 for Assertio Therapeutics, Inc. From our Stock News Alerts App
March 18th 2019, 8:03am
confcalltran @confcalltran
Director of Depomed just picked up 10,000 shares https://t.co/bQVy48dvhp $DEPO
March 18th 2019, 8:03am
confcalltran @confcalltran
SVP of Depomed just picked up 5,000 shares https://t.co/vQnOhm8aqf $DEPO
March 18th 2019, 8:03am
confcalltran @confcalltran
Depomed's SVP and CFO just picked up 6,000 shares https://t.co/qOa0ANznpr $DEPO
March 18th 2019, 8:03am
CSIMarket @CSIMarket
$DEPO #stock #investing #AssertioTherapeutics publishes on https://t.co/savSNU1XbB reported disastrous forth quar… https://t.co/5MwmnEL5F5
March 12th 2019, 10:03am
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form 10-K (No. 0001005201-19-000040): https://t.co/7wE7VHrJHo
March 11th 2019, 8:03am
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 10-K https://t.co/q7fKNnSG8k
March 11th 2019, 8:03am
Allstocknews @Allstocknews
$DEPO New Form 10-K for Assertio Therapeutics, Inc. From our Stock News Alerts App
March 11th 2019, 8:03am
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form 8-K (No. 0001005201-19-000038): https://t.co/gTcQ02zqEw
March 6th 2019, 4:03pm
Allstocknews @Allstocknews
$DEPO Assertio Therapeutics Announces Fourth-Quarter and Full-Year 2018 Financial Results From our Stock News Alerts App
March 6th 2019, 4:03pm
Allstocknews @Allstocknews
$DEPO Assertio Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results After The Close of From our Stock News Alerts App
February 21st 2019, 4:02pm
Cryptoheadz1 @Cryptoheadz1
Would really like to see updates from Depository Network on @get_delta via their feature #DeltaDirect #depositorynetwork #depo $DEPO
February 21st 2019, 7:02am
confcalltran @confcalltran
Depomed director just declared 0 ownership of the company. https://t.co/Os23ev7chb $DEPO
February 19th 2019, 4:02pm
confcalltran @confcalltran
Depomed director was just granted 43,182 restricted shares https://t.co/UmxnvJOecU $DEPO
February 19th 2019, 4:02pm
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 4 https://t.co/bpzaoanUsz
February 19th 2019, 4:02pm
Allstocknews @Allstocknews
$DEPO New Form 3 for Assertio Therapeutics, Inc. From our Stock News Alerts App
February 19th 2019, 4:02pm
Allstocknews @Allstocknews
$DEPO Assertio Therapeutics Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-act From our Stock News Alerts App
February 19th 2019, 8:02am
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form 8-K (No. 0001005201-19-000027): https://t.co/UO0RNWMlSk
February 19th 2019, 8:02am
Allstocknews @Allstocknews
$DEPO Assertio Therapeutics Announces Appointment of Heather L. Mason to Board of Directors From our Stock News Alerts App
February 19th 2019, 8:02am
confcalltran @confcalltran
Departure of Directors or Certain https://t.co/3RypBvPdn8 $DEPO
February 19th 2019, 8:02am
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 5 https://t.co/IB6rvz1wyd
February 14th 2019, 4:02pm
Allstocknews @Allstocknews
$DEPO New Form 5 for Assertio Therapeutics, Inc. From our Stock News Alerts App
February 14th 2019, 4:02pm
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form SC 13G/A (No. 0000919574-19-001685): https://t.co/vIWMV4MEW1
February 14th 2019, 2:02pm
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form SC 13G/A https://t.co/H9AXlAHkx1
February 14th 2019, 2:02pm
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form SC 13G (No. 0001037389-19-000009): https://t.co/n4UJTWTR6k
February 12th 2019, 2:02pm
confcalltran @confcalltran
Renaissance Technologies LLC just provided an update on share ownership of Depomed https://t.co/0DmdnxoHxe $DEPO
February 12th 2019, 2:02pm
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form SC 13G https://t.co/WuYzaIesK8
February 12th 2019, 2:02pm
confcalltran @confcalltran
The Vanguard Group just provided an update on share ownership of Depomed https://t.co/5ctF28oG64 $DEPO
February 11th 2019, 7:02am
confcalltran @confcalltran
The Vanguard Group just provided an update on share ownership of Depomed https://t.co/Phahgsfvks $DEPO
February 11th 2019, 7:02am
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form SC 13G/A https://t.co/b537CR45E0
February 11th 2019, 7:02am
Allstocknews @Allstocknews
$DEPO New Form SC 13G/A for Assertio Therapeutics, Inc. From our Stock News Alerts App
February 8th 2019, 4:02pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.